We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
1076
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$16K ﹤0.01%
352
BPMC
1077
DELISTED
Blueprint Medicines
BPMC
$15K ﹤0.01%
222
CYTK icon
1078
Cytokinetics
CYTK
$10.6B
$15K ﹤0.01%
319
GBT
1079
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15K ﹤0.01%
214
ALKS icon
1080
Alkermes
ALKS
$8.11B
$14K ﹤0.01%
609
DNLI icon
1081
Denali Therapeutics
DNLI
$3.79B
$14K ﹤0.01%
458
RY icon
1082
Royal Bank of Canada
RY
$287B
$14K ﹤0.01%
150
+100
+200% +$9.59K
MRTX
1083
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14K ﹤0.01%
207
CCXI
1084
DELISTED
ChemoCentryx, Inc.
CCXI
$14K ﹤0.01%
265
ARWR icon
1085
Arrowhead Research
ARWR
$12.1B
$13K ﹤0.01%
394
EWW icon
1086
iShares MSCI Mexico ETF
EWW
$1.89B
$13K ﹤0.01%
300
MRVI icon
1087
Maravai LifeSciences
MRVI
$972M
$13K ﹤0.01%
490
PTCT icon
1088
PTC Therapeutics
PTCT
$6.18B
$13K ﹤0.01%
266
BEAM icon
1089
Beam Therapeutics
BEAM
$2.68B
$12K ﹤0.01%
262
OUT icon
1090
Outfront Media
OUT
$5.75B
$12K ﹤0.01%
787
+189
+32% +$3.33K
FOLD
1091
DELISTED
Amicus Therapeutics
FOLD
$11K ﹤0.01%
1,044
RARE icon
1092
Ultragenyx Pharmaceutical
RARE
$2.46B
$11K ﹤0.01%
261
XOS icon
1093
Xos
XOS
$26.8M
$11K ﹤0.01%
+312
New +$16K
ABCL icon
1094
AbCellera Biologics
ABCL
$1.65B
$10K ﹤0.01%
1,060
HRMY icon
1095
Harmony Biosciences
HRMY
$2.08B
$10K ﹤0.01%
220
INSM icon
1096
Insmed
INSM
$22.4B
$10K ﹤0.01%
445
VIR icon
1097
Vir Biotechnology
VIR
$1.46B
$10K ﹤0.01%
493
ARVN icon
1098
Arvinas
ARVN
$530M
$9K ﹤0.01%
198
BCRX icon
1099
BioCryst Pharmaceuticals
BCRX
$2.42B
$9K ﹤0.01%
692
LOPE icon
1100
Grand Canyon Education
LOPE
$4.22B
$9K ﹤0.01%
115
-385
-77% -$33.4K

Similar funds

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.